期刊文献+

雷贝拉唑预防老年NSAIDS相关性上消化道粘膜损害临床观察

雷贝拉唑预防老年NSAIDS相关性上消化道粘膜损害临床观察
下载PDF
导出
摘要 目的观察雷贝拉唑预防老年患者非甾体抗炎药相关性上消化道粘膜损害的疗效。结果治疗组病人上消化道粘膜损害率为2.78%,对照组上消化道粘膜损害率为22.3%,差异有显著性(P<0.05)。 Objective Chaleibeila yl prevention of elderly patients with NSAID--related upper gastrointestinal mucosal damage effect. Results The patients with upper gastrointestinal mucosal damage was 2.78%,upper gastrointestinal mucosal damage to the control group was 22.3%,the difference was significant (P〈0.05).
出处 《中外医疗》 2012年第7期90-90,共1页 China & Foreign Medical Treatment
关键词 雷贝拉唑 老年 非甾体抗炎药 上消化道粘膜损害 Rabeprazole Elderly NSAID Upper gastrointestinal mucosal damage
  • 相关文献

参考文献2

二级参考文献3

  • 1[1]Lichtenstein D, Syngal S, Wife MM. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract[J]. Arthritis Rheum, 1995;38:1:5-18
  • 2[2]Bjamason I, Macpherson A, Somasundaram S, et al. Lower bowel toxicity of non-steroidal anti-inflammatory drugs[A]. Lewis A,Furst D. Non-steroidal Anti-Inflammatory Drugs. Mechanisms and Clinical Uses[M]. New York: NY, Marcel Dekker, 1994:145-157.
  • 3[3]James FF, Catherine AW, Daniel AB, et al. Nonsteroidal antiinflammatory drug associated gastropathy: in cidence and risk factor models[J]. Am JMed, 1991; 91:213-222.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部